Long-term results of the Burch-Schneider antiprotrusio cage: a single-centre follow-up of 144 cases after a minimum of 5 years.

Stark, Thomas; Stoffel, Karl; Ilchmann, Thomas; Gahl, Brigitta; Zwicky, Lukas; Ochsner, Peter E; Clauss, Martin · Hip Int · 2025

retrospective_cohort · Level III

Where this comes from

Abstract

Although the Burch-Schneider antiprotrusio cage (BS-APC) has been reported to be reliable, long-term data for this implant are scarce. We thus aimed to investigate survival and radiological results for revision total hip arthroplasty with the BS-APC in patients with major bone deficiency (55% AAOS defect grade 3, 39% grade 4) who had a minimum follow-up of 5 years (mean 10.2 years). 144 revisions in 140 patients were performed due to aseptic loosening (<i>n</i> <i>=</i> 74), infection (<i>n</i> = 50), or other reasons (<i>n</i> = 20). Survival analysis was performed with death as a competing risk. Clinical follow-up was performed at 1, 2, and 5 years and every 5 years thereafter. 77 patients died during follow-up, 25 within the first 5 years. 12 BS-APCs were re-revised for infection (<i>n</i> = 5), aseptic loosening (<i>n</i> = 5), or instability (<i>n</i> = 2). The cumulative incidence for aseptic re-revision of BS-APCs was 4.3% at 10 years (95% CI, 1.8-10.1%), and the cumulative risk of death was 73.3% (95% CI, 62.4-83.2%). Radiological changes occurred in 26 of 87 radiologically examined hips, of which 8 cases were revised. We found excellent mid- and long-term survival of the BS-APC in acetabular revision with major bone deficiencies, in accordance with or superior to most literature reports, which might be explained by strict adherence to surgical technique.

Medical subject headings

Anatomy